A citation-based method for searching scientific literature

S Suwannaroj, A Lagoo, D Keisler, R W McMurray. Lupus 2001
Times Cited: 70







List of co-cited articles
666 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


N-acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: a randomized, double-blind, placebo-controlled trial.
Zhi-Wei Lai, Robert Hanczko, Eduardo Bonilla, Tiffany N Caza, Brandon Clair, Adam Bartos, Gabriella Miklossy, John Jimah, Edward Doherty, Hajra Tily,[...]. Arthritis Rheum 2012
198
42

Rapamycin reduces disease activity and normalizes T cell activation-induced calcium fluxing in patients with systemic lupus erythematosus.
David Fernandez, Eduardo Bonilla, Naureen Mirza, Brian Niland, Andras Perl. Arthritis Rheum 2006
200
35

Mitochondrial hyperpolarization and ATP depletion in patients with systemic lupus erythematosus.
Peter Gergely, Craig Grossman, Brian Niland, Ferenc Puskas, Hom Neupane, Fatme Allam, Katalin Banki, Paul E Phillips, Andras Perl. Arthritis Rheum 2002
201
31

Activation of mammalian target of rapamycin controls the loss of TCRzeta in lupus T cells through HRES-1/Rab4-regulated lysosomal degradation.
David R Fernandez, Tiffany Telarico, Eduardo Bonilla, Qing Li, Sanjay Banerjee, Frank A Middleton, Paul E Phillips, Mary K Crow, Stefanie Oess, Werner Muller-Esterl,[...]. J Immunol 2009
148
24



High-dose acetylcysteine in idiopathic pulmonary fibrosis.
Maurits Demedts, Juergen Behr, Roland Buhl, Ulrich Costabel, Richard Dekhuijzen, Henk M Jansen, William MacNee, Michiel Thomeer, Benoit Wallaert, François Laurent,[...]. N Engl J Med 2005
639
14

Nitric oxide-dependent mitochondrial biogenesis generates Ca2+ signaling profile of lupus T cells.
Gyorgy Nagy, Maureen Barcza, Nick Gonchoroff, Paul E Phillips, Andras Perl. J Immunol 2004
80
14

Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets.
Ryan D Michalek, Valerie A Gerriets, Sarah R Jacobs, Andrew N Macintyre, Nancie J MacIver, Emily F Mason, Sarah A Sullivan, Amanda G Nichols, Jeffrey C Rathmell. J Immunol 2011
14

Normalization of CD4+ T cell metabolism reverses lupus.
Yiming Yin, Seung-Chul Choi, Zhiwei Xu, Daniel J Perry, Howard Seay, Byron P Croker, Eric S Sobel, Todd M Brusko, Laurence Morel. Sci Transl Med 2015
291
14


Markers of oxidative and nitrosative stress in systemic lupus erythematosus: correlation with disease activity.
Gangduo Wang, Silvia S Pierangeli, Elizabeth Papalardo, G A S Ansari, M Firoze Khan. Arthritis Rheum 2010
131
12

Sirolimus in patients with clinically active systemic lupus erythematosus resistant to, or intolerant of, conventional medications: a single-arm, open-label, phase 1/2 trial.
Zhi-Wei Lai, Ryan Kelly, Thomas Winans, Ivan Marchena, Ashwini Shadakshari, Julie Yu, Maha Dawood, Ricardo Garcia, Hajra Tily, Lisa Francis,[...]. Lancet 2018
149
12


Glutathione levels and sensitivity to apoptosis are regulated by changes in transaldolase expression.
K Banki, E Hutter, E Colombo, N J Gonchoroff, A Perl. J Biol Chem 1996
159
11

Mitochondrial hyperpolarization: a checkpoint of T-cell life, death and autoimmunity.
Andras Perl, Peter Gergely, Gyorgy Nagy, Agnes Koncz, Katalin Banki. Trends Immunol 2004
159
11


Metabolic control of T cell activation and death in SLE.
David Fernandez, Andras Perl. Autoimmun Rev 2009
70
11

Lipid peroxidation is enhanced in patients with systemic lupus erythematosus and is associated with arterial and renal disease manifestations.
Johan Frostegård, Elisabet Svenungsson, Ruihua Wu, Iva Gunnarsson, Ingrid E Lundberg, Lars Klareskog, Sohvi Hörkkö, Joseph L Witztum. Arthritis Rheum 2005
170
11

The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2.
Greg M Delgoffe, Kristen N Pollizzi, Adam T Waickman, Emily Heikamp, David J Meyers, Maureen R Horton, Bo Xiao, Paul F Worley, Jonathan D Powell. Nat Immunol 2011
707
11

Systemic lupus erythematosus.
George C Tsokos. N Engl J Med 2011
11

Mechanistic target of rapamycin activation triggers IL-4 production and necrotic death of double-negative T cells in patients with systemic lupus erythematosus.
Zhi-Wei Lai, Rebecca Borsuk, Ashwini Shadakshari, Jianghong Yu, Maha Dawood, Ricardo Garcia, Lisa Francis, Hajra Tily, Adam Bartos, Stephen V Faraone,[...]. J Immunol 2013
75
11

HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells.
Lewis Z Shi, Ruoning Wang, Gonghua Huang, Peter Vogel, Geoffrey Neale, Douglas R Green, Hongbo Chi. J Exp Med 2011
982
11

Aberrant processing of oxidative DNA damage in systemic lupus erythematosus.
M D Evans, M S Cooke, M Akil, A Samanta, J Lunec. Biochem Biophys Res Commun 2000
49
14


FKBP12-rapamycin-associated protein associates with mitochondria and senses osmotic stress via mitochondrial dysfunction.
Bimal N Desai, Benjamin R Myers, Stuart L Schreiber. Proc Natl Acad Sci U S A 2002
192
10



Comprehensive metabolome analyses reveal N-acetylcysteine-responsive accumulation of kynurenine in systemic lupus erythematosus: implications for activation of the mechanistic target of rapamycin.
Andras Perl, Robert Hanczko, Zhi-Wei Lai, Zachary Oaks, Ryan Kelly, Rebecca Borsuk, John M Asara, Paul E Phillips. Metabolomics 2015
66
10

8-Hydroxydeoxyguanosine. A marker of oxidative DNA damage in systemic lupus erythematosus.
J Lunec, K Herbert, S Blount, H R Griffiths, P Emery. FEBS Lett 1994
119
8


Interleukin-10 promotes activation-induced cell death of SLE lymphocytes mediated by Fas ligand.
L Georgescu, R K Vakkalanka, K B Elkon, M K Crow. J Clin Invest 1997
143
8

Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys.
José C Crispín, Mohamed Oukka, George Bayliss, Robert A Cohen, Christine A Van Beek, Isaac E Stillman, Vasileios C Kyttaris, Yuang-Taung Juang, George C Tsokos. J Immunol 2008
482
8

Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II/III systemic lupus erythematosus evaluation of rituximab trial.
Joan T Merrill, C Michael Neuwelt, Daniel J Wallace, Joseph C Shanahan, Kevin M Latinis, James C Oates, Tammy O Utset, Caroline Gordon, David A Isenberg, Hsin-Ju Hsieh,[...]. Arthritis Rheum 2010
721
8

Oxidative stress in systemic lupus erythematosus: relationship to Th1 cytokine and disease activity.
Dilip Shah, Ravi Kiran, Ajay Wanchu, Archana Bhatnagar. Immunol Lett 2010
62
9

Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial.
Sandra V Navarra, Renato M Guzmán, Alberto E Gallacher, Stephen Hall, Roger A Levy, Renato E Jimenez, Edmund K-M Li, Mathew Thomas, Ho-Youn Kim, Manuel G León,[...]. Lancet 2011
991
8


The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment.
Greg M Delgoffe, Thomas P Kole, Yan Zheng, Paul E Zarek, Krystal L Matthews, Bo Xiao, Paul F Worley, Sara C Kozma, Jonathan D Powell. Immunity 2009
784
8

Attention deficit and hyperactivity disorder scores are elevated and respond to N-acetylcysteine treatment in patients with systemic lupus erythematosus.
Ricardo J Garcia, Lisa Francis, Maha Dawood, Zhi-Wei Lai, Stephen V Faraone, Andras Perl. Arthritis Rheum 2013
55
10

The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation.
Ruoning Wang, Christopher P Dillon, Lewis Zhichang Shi, Sandra Milasta, Robert Carter, David Finkelstein, Laura L McCormick, Patrick Fitzgerald, Hongbo Chi, Joshua Munger,[...]. Immunity 2011
8

Mitochondrial respiratory capacity is a critical regulator of CD8+ T cell memory development.
Gerritje J W van der Windt, Bart Everts, Chih-Hao Chang, Jonathan D Curtis, Tori C Freitas, Eyal Amiel, Edward J Pearce, Erika L Pearce. Immunity 2012
808
8


Oxygen free radicals and systemic autoimmunity.
H Ahsan, A Ali, R Ali. Clin Exp Immunol 2003
150
7

Serum oxidant/antioxidant status of patients with systemic lupus erythematosus.
Seyithan Taysi, Mustafa Gul, Refik Ali Sari, Fatih Akcay, Nuri Bakan. Clin Chem Lab Med 2002
71
7

Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study.
S Manzi, E N Meilahn, J E Rairie, C G Conte, T A Medsger, L Jansen-McWilliams, R B D'Agostino, L H Kuller. Am J Epidemiol 1997
7

Trichloroethene-induced autoimmune response in female MRL +/+ mice.
M F Khan, B S Kaphalia, B S Prabhakar, M F Kanz, G A Ansari. Toxicol Appl Pharmacol 1995
90
7

Clinical and serologic manifestations of autoimmune disease in MRL-lpr/lpr mice lacking nitric oxide synthase type 2.
G S Gilkeson, J S Mudgett, M F Seldin, P Ruiz, A A Alexander, M A Misukonis, D S Pisetsky, J B Weinberg. J Exp Med 1997
83
7

Rapamycin promotes expansion of functional CD4+CD25+FOXP3+ regulatory T cells of both healthy subjects and type 1 diabetic patients.
Manuela Battaglia, Angela Stabilini, Barbara Migliavacca, Jutta Horejs-Hoeck, Thomas Kaupper, Maria-Grazia Roncarolo. J Immunol 2006
527
7




Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.